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Abstract: BACKGROUND Inadequate coronary adenosine response is a potential cause for false negative
ischemia testing. Recently, the splenic switch-off (SSO) sign has been identified as a promising tool to
ascertain the efficacy of adenosine during vasodilator stress cardiovascular magnetic resonance imaging
(CMR). We assessed the value of SSO to predict adenosine response, defined as an increase in myocardial
blood flow (MBF) during quantitative stress myocardial perfusion 13 N-ammonia positron emission to-
mography (PET). METHODS We prospectively enrolled 64 patients who underwent simultaneous CMR
and PET myocardial perfusion imaging on a hybrid PET/CMR scanner with co-injection of gadolinium
based contrast agent (GBCA) and 13N-ammonia during rest and adenosine-induced stress. A myocar-
dial flow reserve (MFR) of > 1.5 or ischemia as assessed by PET were defined as markers for adequate
coronary adenosine response. The presence or absence of SSO was visually assessed. The stress-to-rest
intensity ratio (SIR) was calculated as the ratio of stress over rest peak signal intensity for splenic tissue.
Additionally, the spleen-to-myocardium ratio, defined as the relative change of spleen to myocardial sig-
nal, was calculated for stress (SMRstress) and rest. RESULTS Sixty-one (95%) patients were coronary
adenosine responders, but SSO was absent in 18 (28%) patients. SIR and SMRstress were significantly
lower in patients with SSO (SIR: 0.56 ± 0.13 vs. 0.93 ± 0.23; p < 0.001 and SMRstress: 1.09 ± 0.47 vs.
1.68 ± 0.62; p < 0.001). Mean hyperemic and rest MBF were 2.12 ± 0.68 ml/min/g and 0.78 ± 0.26
ml/min/g, respectively. MFR was significantly higher in patients with vs. patients without presence of
SSO (3.07 ± 1.03 vs. 2.48 ± 0.96; p = 0.038), but there was only a weak inverse correlation between
SMRstress and MFR (R = -0.378; p = 0.02) as well as between SIR and MFR (R = -0.356; p = 0.004).
CONCLUSIONS The presence of SSO implies adequate coronary adenosine-induced MBF response. Its
absence, however, is not a reliable indicator for failed adenosine-induced coronary vasodilatation.
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Abstract 
Background: Inadequate coronary adenosine response is a potential cause for false negative ischemia testing. 
Recently, the splenic switch-off (SSO) sign has been identified as a promising tool to ascertain the efficacy of adeno-
sine during vasodilator stress cardiovascular magnetic resonance imaging (CMR). We assessed the value of SSO to 
predict adenosine response, defined as an increase in myocardial blood flow (MBF) during quantitative stress myocar-
dial perfusion 13 N-ammonia positron emission tomography (PET).
Methods: We prospectively enrolled 64 patients who underwent simultaneous CMR and PET myocardial perfusion 
imaging on a hybrid PET/CMR scanner with co-injection of gadolinium based contrast agent (GBCA) and 13N-ammo-
nia during rest and adenosine-induced stress. A myocardial flow reserve (MFR) of  > 1.5 or ischemia as assessed by 
PET were defined as markers for adequate coronary adenosine response. The presence or absence of SSO was visually 
assessed. The stress-to-rest intensity ratio (SIR) was calculated as the ratio of stress over rest peak signal intensity for 
splenic tissue. Additionally, the spleen-to-myocardium ratio, defined as the relative change of spleen to myocardial 
signal, was calculated for stress  (SMRstress) and rest.
Results: Sixty-one (95%) patients were coronary adenosine responders, but SSO was absent in 18 (28%) patients. 
SIR and  SMRstress were significantly lower in patients with SSO (SIR: 0.56 ± 0.13 vs. 0.93 ± 0.23; p < 0.001 and  SMRstress: 
1.09 ± 0.47 vs. 1.68 ± 0.62; p < 0.001). Mean hyperemic and rest MBF were 2.12 ± 0.68 ml/min/g and 0.78 ± 0.26 ml/
min/g, respectively. MFR was significantly higher in patients with vs. patients without presence of SSO (3.07 ± 1.03 vs. 
2.48 ± 0.96; p = 0.038), but there was only a weak inverse correlation between  SMRstress and MFR (R = -0.378; p = 0.02) 
as well as between SIR and MFR (R = -0.356; p = 0.004).
Conclusions: The presence of SSO implies adequate coronary adenosine-induced MBF response. Its absence, how-
ever, is not a reliable indicator for failed adenosine-induced coronary vasodilatation.
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Background
Due to its rapid onset of action, its short half-life and 
the good tolerability and safety profile, adenosine is a 
widely used vasodilator for ischemia testing in myo-
cardial perfusion imaging (MPI) using single photon 
emission computed tomography (SPECT), positron 
emission tomography (PET), and cardiovascular mag-
netic resonance imaging (CMR). However, induction of 
maximal coronary vasodilation is a crucial prerequisite 
for obtaining high diagnostic accuracy concerning the 
detection of obstructive coronary artery disease (CAD) 
[1–4]. Whether this condition is achieved remains diffi-
cult to assess in clinical routine because commonly used 
markers such as the hemodynamic response to adeno-
sine (i.e., a decrease in systolic blood pressure and/or 
increase in heart rate) are unreliable as they are prone to 
procedure-related confounders such as anxiety or aden-
osine-induced side effects [5, 6]. Recently, the splenic 
switch-off (SSO) sign has been proposed as a more objec-
tive and direct marker of adequate adenosine response 
during stress CMR [7]. SSO has been defined as a vis-
ible decrease in splenic signal intensity during adenosine 
stress as compared to rest, presumably due to reduced 
splenic blood flow which may be mediated through 
reactive sympathetic vasoconstriction after adenosine-
induced hypotension [8].
Contrary to modalities relying on the detection of rela-
tive regional differences in myocardial perfusion, such as 
CMR and SPECT, PET MPI allows for absolute quantifi-
cation of myocardial blood flow (MBF) and calculation of 
myocardial flow reserve (MFR) [9]. Adenosine-induced 
coronary vasodilation has been shown to increase MBF 
during PET MPI up to fourfold over resting baseline 
[10]. Hence, PET-derived MBF quantification is a reli-
able standard of truth for assessing adequate coronary 
adenosine response. Furthermore, the introduction of 
novel PET/CMR devices, incorporating both modali-
ties in a single hybrid scanner, offers the unique possi-
bility of simultaneous assessment and cross-validation 
of both modalities during co-injection of gadolinium 
based contrast agents (GBCA) and 13N-ammonia [11]. 
Most importantly, the simultaneity of PET and CMR data 
acquisition during the same adenosine stimulus ensures 
an identical physiological state of the coronary and extra-
cardiac vasculature. We sought to test the hypothesis that 
SSO constitutes a reliable predictor of adequate coronary 
adenosine response. MFR served as the standard of truth 
and was assessed on a PET/CMR device with co-injection 
of 13N-ammonia and GBCA during adenosine stress.
Methods
Study design and population
Data of this prospective single-center study were derived 
from ongoing PET/CMR projects. We assessed patients 
who underwent cardiac PET/CMR for evaluation of 
CAD or cardiomyopathy. Written informed consent was 
obtained from all participants, and the study protocol 
was approved by the local ethics committee (KEK-ZH-
Nr. 2014-0187 and BASEC-Nr. 2018-00170). Patients 
aged ≥ 18  years without any contraindications against 
CMR (e.g., implanted cardiac devices, claustrophobia, 
known GBCA allergy, severe renal impairment), adeno-
sine (e.g., asthma, atrioventricular block), or PET (e.g., 
pregnancy or breastfeeding) were included. This study 
was partially funded by the Swiss National Science Foun-
dation (SNSF Project Nr. 175640).
Hybrid PET/CMR perfusion imaging
CMR and PET datasets were acquired using a hybrid 
PET/CMR device incorporating a 3 T CMR and a latest-
generation PET scanner with time-of-flight (TOF) (Signa 
PET/MR, GE Healthcare, Waukesha, Wisconsin, USA). 
All patients were asked to refrain from caffeine intake 
for at least 12 h before the examination. The stress pro-
tocol consisted of 6  min of adenosine infusion with a 
weight-adapted dose of adenosine (140  μg/kg/min). A 
body mass index adapted dose of 13N-ammonia (i.e., 
200–600 megabecquerels (MBq) and a weight-adapted 
dose of GBCA (Gadovist, Bayer AG, Berlin, Germany) 
(0.1  mmol/kg) was simultaneously injected 3  min into 
adenosine stress. Dynamic PET data acquisition con-
sisted of 21 frames (i.e., 9 × 10-s, 6 × 15-s, 3 × 20-s, 
2 × 30-s, and 1 × 120-s), followed by an electrocardio-
gram (ECG)-gated static acquisition over 10  min. Rest-
ing perfusion imaging was performed using an identical 
acquisition protocol after a minimum of 15 min following 
the stress acquisition according to Society for Cardiovas-
cular Magnetic Resonance (SCMR) guidelines [12]. All 
PET data were acquired in 3D mode and reconstructed 
using TOF reconstruction with VUE Point FX (2 itera-
tions and 16 subsets) and 5-mm Hanning filter. Standard 
DIXON-based maps were used for attenuation correc-
tion [13]. Summed semi-quantitative myocardial PET 
tracer uptake and quantitative MBF was obtained from 
stress and rest scans and analyzed using QPET (Version 
2015, Cedars-Sinai Medical Center, Los Angeles, Califor-
nia, USA). Datasets were examined in consensus by two 
experienced readers regarding the presence of ischemia 
and/or scar.
Keywords: Splenic switch-off, Cardiovascular magnetic resonance imaging, Myocardial perfusion imaging
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CMR stress and rest perfusion scans were acquired 
using three left ventricular short-axis slices per car-
diac cycle (basal, mid, and apical levels) each of 10 mm 
slice thickness and ECG-gated breath-hold protocol. A 
T1 weighted fast gradient echo sequence with short TR 
and TE (TR 3.3  ms TE 1.2  ms, flip angle 20°) was used 
for stress and rest perfusion with a typical acquired voxel 
size of 2.9 × 2.9  mm2 and typical matrix size of 128 × 128 
(frequency × phase). A 90-degree non-selective satu-
ration preparation pulse was applied prior to every 
acquired slice with a saturation delay time of 100  ms. 
A parallel imaging acceleration factor of 2 was used to 
reduce slice acquisition time. Heart rate (HR) and blood 
pressure were monitored during the stress and rest 
scans. A HR increase ≥ 10 beats per minute (bpm) was 
regarded as a positive HR response to adenosine [14]. 
However, as HR response has been shown to be influ-
enced by several parameters like age and sex [15], we 
used MFR as assessed by PET to define true coronary 
adenosine response. Taking into account a reported day-
to-day intra-subject variability of MFR of up to 20% [16], 
we defined an MFR of > 1.5 or the presence of ischemia 
on PET as markers for adequate coronary adenosine 
response.
Visual and quantitative assessment of SSO
Presence of SSO was defined as a visually perceivable 
lower splenic enhancement on stress than on rest first-
pass CMR images, as previously reported [7]. Visual 
analysis was performed independently by two readers in 
a blinded fashion. In cases of disagreement between the 
readers, the decision was made by consensus. Inter-rater 
variability was calculated using Cohen’s Kappa (κ). Grey-
scale values were normalized, and identical thresholds 
were used for stress and rest images for better compa-
rability using a commercially available software package 
(Circle 42, Version 5.6.4, Circle Cardiovascular Imaging, 
Calgary, Canada).
Myocardial signal intensity curves during first-pass 
perfusion were derived from CMR. In addition, regions 
of interest were drawn in the spleen. Corrected peak 
signal intensity of the spleen was calculated for stress 
and rest by subtracting baseline intensity (pre-contrast) 
from peak intensity after first-pass perfusion. Stress-
to-rest intensity ratio (SIR) was calculated as the ratio 
between corrected peak signal intensity of stress and rest 
images for splenic tissue as previously reported (Fig.  1) 
[14]. Finally, spleen-to-myocardium intensity ratios for 
stress  (SMRstress) were calculated, defined as the ratio of 
increase of spleen activity to myocardial intensity during 
stress and rest, respectively, to ensure standardized eval-
uation (Fig. 1).
Statistical analysis
Descriptive statistics were used to examine clinical 
data. Values are presented as averages ± standard devi-
ations or as total numbers and as percentages, where 
applicable. Patients were stratified into groups accord-
ing to the presence or absence of SSO and according to 
a positive or negative HR response (i.e., ≥ or < 10  bpm 
increase upon adenosine stress). Comparison between 
the groups was performed using a Chi2-test in nominal 
or students’ t-test and Mann–Whitney-test in normally 
distributed and non-parametric variables, respectively. 
Correlation analysis between SIR and MFR, SMR and 
MFR, as well as between the HR increase from rest to 
stress and MFR was performed using Pearson analy-
sis. A cut-off value for SIR and SMR for predicting the 
presence of SSO was calculated using receiver operat-
ing characteristic (ROC) analysis. Statistical analy-
sis was performed using SPSS (version 22, Statistical 
Package for the Social Sciences, International Business 
Machines, Inc., Armonk, New York, USA).
Results
Baseline characteristics
A total of 67 patients were included in our study. The 
spleen was visible within the CMR field-of-view in 64 
(96%) patients. The remaining 3 (4%) patients were 
excluded from further investigations. Baseline charac-
teristics and PET findings are given in Table 1.
13N‑ammonia PET myocardial perfusion imaging
The mean injected activity of 13N-ammonia during 
PET was 297 ± 98  MBq and 463 ± 103  MBq for stress 
and rest imaging, respectively. Mean hyperemic and 
rest MBF were 2.1 ± 0.7  ml/min/g and 0.8 ± 0.3  ml/
min/g, respectively. Mean MFR was 2.9 ± 1.0. Three 
(5%) patients with an MFR ≤ 1.5 and without any signs 
of ischemia neither in PET nor CMR were classified 
as adenosine non-responders. Three (5%) additional 
patients with severe coronary artery disease had an 
MFR ≤ 1.5 but presented with clear signs of ischemia in 
13 N-ammonia PET and CMR and were therefore clas-
sified as adenosine responders.
SSO and quantitative assessment of splenic perfusion
SSO was present in 46 (72%) patients. Inter-rater reli-
ability was excellent (κ = 0.906; p < 0.001). Among the 
three adenosine non-responders, two patients did not 
present with SSO, but one patient  showed SSO. MFR 
differed significantly in patients with vs. patients with-
out presence of SSO (3.1 ± 1.0 vs. 2.5 ± 1.0; p = 0.038). 
Splenic stress-to-rest SIR was significantly lower in 
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patients with vs. patients without presence of SSO (SIR: 
0.56 ± 0.13 vs. 0.93 ± 0.23; p < 0.001).
ROC analysis yielded an optimal cut-off value of SIR 
for predicting presence of SSO of 0.71 (sensitivity: 94%; 
specificity: 94%; AUC = 0.947).  SMRstress was significantly 
lower in patients with vs. patients without presence 
of SSO (1.1 ± 0.5 vs. 1.7 ± 0.6; p < 0.001). ROC analysis 
yielded an optimal cut-off value of  SMRstress for predict-
ing presence of SSO of 1.53 (sensitivity: 61%; specificity: 
85%; AUC = 0.76).
A weak correlation was found between MFR and SIR 
(R = -0.356; p = 0.004) as well as between MFR and 
 SMRstress (R = -0.378; p = 0.02). By contrast, there was 
no correlation between  SMRstresst or SIR and the total 
increase of HR during adenosine  (SMRstress: R = -0.115; 
p = 0.37, SIR: R = -0.143; p = 0.26).
HR response
HR increased significantly from rest to stress (62 ± 10 vs. 
74 ± 19 bpm, p < 0.001), and 29 (45%) patients had a posi-
tive HR increase of ≥ 10 bpm. There was a trend towards 
higher MFR in patients with vs. patients without a posi-
tive HR response (3.2 vs 2.7  ml/min/g; p = 0.053) but 
there was no difference in the proportion of patients with 
and without a positive HR response among patients with 
or without SSO (p = 0.23).
Discussion
To the best of our knowledge, this is the first study 
investigating the performance of SSO to predict coro-
nary adenosine response on a hybrid PET/CMR device 
with co-injection of GBCA and 13N-ammonia using 
PET-derived MFR as the standard of truth. While we 
found that 95% of the patients were coronary adenosine 
Fig. 1 Example of presence of splenic switch-off sign (SSO) (*) with signal intensity curves. a Stress perfusion, b rest perfusion. 
SMR  spleen-myocardium intensity ratio, SIR stress-to-rest intensity ratio for spleen
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responders, SSO was absent in 28% of the patients. Fur-
thermore, there was only a weak correlation between 
SMR and MFR as well as between SIR and MFR. Hence, 
from our results, we conclude that the absence of SSO 
should not necessarily lead to the conclusion that a 
patient failed to respond to adenosine. By contrast, how-
ever, the presence of SSO in case of normal stress perfu-
sion CMR is a strong indicator for a true negative finding.
Our findings are in line with the results of Kuijpers 
et  al. who demonstrated that SSO failed to predict 
adenosine non-responders after caffeine intake [17]. 
By contrast, Manisty et  al. assessed a sub-population of 
the CE-MARC study, comparing 35 false negative CMR 
scans (defined as normal CMR but significant coronary 
lesion in quantitative coronary angiography) with 65 
true negative CMR scans in a blinded fashion  [7, 18]. 
They found that the absence of SSO was almost four 
times more likely in patients with a false negative CMR 
than in patients with a true negative finding. Hence, the 
authors concluded that absence of SSO may be a predic-
tor of inadequate coronary response to adenosine infu-
sion [7]. However, one limitation of this study was the 
highly ambiguous standard of truth consisting solely of 
the hemodynamic response. By contrast, by performing 
co-injection on a PET/MR device, the current study uses 
a solid standard of reference in the form of PET-derived 
MFR.
In our study, SSO was present in 72% of the patients, 
a proportion which is slightly lower than previously 
described by Manisty et al. (90%) [7] and Hosking et al. 
(89%) [14]. However, our calculated thresholds of 0.71 for 
SIR for predicting visually perceivable SSO was higher 
than in the study by Hosking et  al., which reported 
a threshold of 0.4 [14]. This more sensitive approach 
should have led to an even higher presence of SSO. Of 
note, however, both Manisty et al. [7] and Hosking et al. 
Table 1 Baseline characteristics and comparison of PET results of patients with positive vs negative splenic switch off
Values given are average ± standard deviations or absolute numbers and percentages (in brackets)
ACE  angiotensin converting enzyme, CABG  coronary artery bypass graft, CAD  coronary artery disease, MBF  myocardial blood flow, MFR  myocardial flow reserve. 




n = 46 (72%)
SSO absent
n = 18 (28%)
p‑Value
Baseline characteristics
Mean age (years) 51 ± 20 51.4 ± 18 49.2 ±24 0.69
Male gender 52 (81) 37 (80) 15 (83) 0.30
Weight (kg) 80 ± 11 81 ± 10 75 ± 12 0.047
Height (cm) 175 ± 8 175 ± 8 176 (± 8 0.65
Body mass index(kg/m2) 26 ± 3 27 ± 3 24 ± 3 0.006
Risk factors
Diabetes mellitus 5 (7.8) 5 (11) 0 (0) 0.145
Dyslipidaemia 27 (42) 21 (46) 6 (34) 0.37
Hypertension 25 (39) 20 (43) 5 (28) 0.247
Family history 16 (25) 12 (26) 4 (23) 0.748
Smoking 21 (33) 17 (37) 4 (23) 0.259
Medication
Aspirin 24 (38) 17 (37) 7(39) 0.886
Betablocker 18 (28) 15 (33) 3 (17) 0.202
ACE inhibitor 24 (38) 18 (39) 6 (34) 0.667
Statin 27 (42) 19 (41) 8 (45) 0.819
Medical history
Myocardial infarction 10 (16) 7 (15) 3 (17) 0.886
Stenting 18 (28) 13 (28) 5 (28) 0.969
CABG 7 (11) 4 (9) 3 (170) 0.358
13N-ammonia PET
Ischemia 15 (23) 9 (20) 6 (34) 0.242
Scar 33 (52) 22 (48) 11 (61) 0.1
Stress MBF (ml/min/g) 2.12 ± 0.68 2.2 ± 0.66 1.93 ± 0.72 0.23
Rest MBF (ml/min/g) 0.78 ± 0.26 0.77 ± 0.27 0.81 ± 0.24 0.65
MFR 2.91 (± 1) 3.07 ± 1.03 2.48 ± 0.96 0.038
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[14] increased the injected dose of adenosine in patients 
who failed to show hemodynamic changes during stress. 
By contrast, in the present study, we infused a fixed dose 
of 140 ug/kg/min. The literature on the adequate dose 
of adenosine reveals conflicting results with some stud-
ies raising the question whether adenosine infusion at a 
standard rate of 140 ul/kg/min induces maximal coro-
nary vasodilation in all patients [19, 20]. Other studies 
have demonstrated that increasing the dose of adenosine 
beyond 140 ug/kg/min does not result in further coro-
nary vasodilation [21, 22], but only induces a more aggra-
vated peripheral hemodynamic response [20], potentially 
yielding a higher rate of SSO but without a positive effect 
on the coronary arteries. Hemodynamic response, as 
well as SSO are peripheral side effects induced by A2B 
receptors due to aortic hypotension with consequent 
reflex tachycardia and vasoconstriction of vascular beds 
in order to maintain mean arterial pressure. By contrast, 
coronary vasodilatation is induced through stimulation 
of A2A receptors [2]. In view of the different receptors, 
however, it may seem inadequate to draw conclusions as 
to the extent of coronary vasodilation through extrapola-
tion of any observed peripheral effects. Moreover, accu-
rate assessment of the splenic perfusion itself is difficult 
and may be hampered due to the spleen’s physiologically 
inhomogeneous perfusion of the red and white pulp. 
Hence, areas of lower and higher perfusion are simulta-
neously assessed by CT, ultrasound, and CMR during the 
arterial phase of perfusion [23, 24]. Finally, spleen visu-
alization and analysis during myocardial perfusion imag-
ing are currently not standardized. In the present study, 
one patient without SSO was classified as an adenosine 
responder as per the standard of reference. Of note, how-
ever, the SIR in this patient was 0.68 which lies slightly 
below the calculated SIR-threshold (i.e., 0.71) neces-
sary to allow for visual recognition of SSO. This find-
ing underlines the potential shortcomings and inherent 
uncertainties of a visual assessment of SSO. However, the 
future clinical value of SSO should be put into perspec-
tive as the advent of vasodilators such as regadenoson, 
which are more specific to A2A receptors and may con-
fer a better safety profile than adenosine, may gradually 
reduce the clinical value of the latter in the future.
The present study extends our knowledge and under-
standing of the SSO sign. While our results question 
its value as a reliable marker of inadequate adenosine 
response, future prospective studies—ideally placebo- or 
caffeine-controlled—are also needed. It is noteworthy 
and important, however, that our results on the other 
hand also carry the reassuring message that the presence 
of SSO is a strong marker for adequate coronary adeno-
sine response, therefore increasing a readers’ confidence 
in case of a normal CMR myocardial perfusion scan.
Limitations
In the present study, we used a binary system to classify 
patients into responders vs. non-responders. This may be 
seen as an over-simplification in light of some studies sug-
gesting a more graduated adenosine response, depending 
on receptor density and responsiveness of adenosine recep-
tors [25].
Conclusion
The presence of SSO implies adequate coronary adeno-
sine-induced MBF response. Its absence, however, is not 
a reliable indicator for failed adenosine-induced coronary 
vasodilatation.
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